How to identify counterfeit Amgen Neupogen - FDA Warning
Amgen: Neupogen - FDA Warning
Product Information:
Filgrastim is marketed by Amgen under the brand name Neupogen, in India it is also marketed by Abbott Healthcare under the brand name Imumax.
A Saint Louis, MO oncologist was reported by the FDA to have pled guilty on charges of distributing and receiving misbranded and adulterated prescription drugs, including the cancer treatment drugs marketed in the United States as Neupogen. The oncologist is reported to have taken 47 different shipments from February through December 2010, according to the FDA press release on the occasion of his guilty plea.